Skip to content

AARD AARD Accrued Liabilities, Current

Accrued Liabilities, Current at other companies

Relmada Therapeutics, Inc. logo
Relmada Therapeutics, Inc.RLMD
Aquestive Therapeutics, Inc. logo
Aquestive Therapeutics, Inc.AQST

Other financials

Income statement

See full
Revenue-
Operating income-$22.5M-115%
Net income-$21.6M-132%
EPS (diluted)-$0.99-39.4%

Balance sheet

See full
Cash & equivalents$62.4M+136%
Total debt$336.0K-53.7%
Total equity$87.0M-42.3%
Total assets$98.6M-37.2%

Cash flow

See full
Operating cash flow-$18.9M-65.7%
CapEx--100%
Free cash flow-$16.8M-117%

Valuation

See full
Market cap$124.35M-58.6%
Enterprise value$62.25M-77.4%

Returns & leverage

See full
Return on equity-58.8%
Debt / equity0.0×
Current ratio8.1×-17.8×

Where this comes from

Reported directly by AARD in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: AARD’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about AARD's accrued liabilities, current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AARD's accrued liabilities, current?
AARD (AARD) reported accrued liabilities, current of $6.78M in Q1 2026.
How has AARD's accrued liabilities, current changed year-over-year?
AARD's accrued liabilities, current increased by 123.6% year-over-year, from $3.03M to $6.78M.